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Bacterial compounds signal the presence of foreign pathogens in the innate immune system. These microbial components are key
players in infectious diseases and implicate toll-like receptors in the activation of inﬂammation and coagulation. Nevertheless, the
existence of a synergistic relationship between peptidoglycan and bacterial DNA on these two physiological responses has not been
investigated. The present study reports new ﬁndings on the regulation of tumor necrosis factor alpha and tissue factor in peripheral
blood mononuclear cells by peptidoglycan and bacterial DNA. These were found to induce tumor necrosis factor alpha and tissue
factor simultaneously and in a synergistic manner. These ﬁndings provide a new proinﬂammatory and procoagulant mechanism
likely to play a role in sepsis pathogenesis.
INTRODUCTION
Toll-like receptors (TLRs) allow the innate im-
mune system to distinctively identify foreign pathogenic
molecules, but, if overstimulated, can become media-
tors of sepsis. Lipopolysaccharide (LPS) is known to play
a critical role in sepsis. However, as our understand-
ing of Gram-negative and Gram-positive infections ex-
pands, other TLRs ligands, including lipoteichoic acid
(LTA), peptidoglycan (PepG), lipoproteins, ﬂagellin, and
CpG-rich unmethylated bacterial DNA (bactDNA), have
been recognized to be involved [1]. PepG, a main compo-
nent of bacterial cell walls, can activate leukocytes, gen-
erate proinﬂammatory cytokines such as tumor necro-
sis factor alpha (TNF-α), interleukin-1 (IL-1), IL-6, and
cause systemic inﬂammatory response syndrome [2, 3, 4].
PepG was also shown to mediate platelet aggregation in
Staphylococcus aureus septicemia [5], induce tissue fac-
tor (TF) in monocytes, and display procoagulant activ-
ity [6]. BactDNA induces the production of TNF-α in
macrophages in vitro. BactDNA leads to septic shock and
deathinsensitivemice[7].Becauseofthecooperationbe-
tween TLRs and the common denominators downstream
of TLR activation, synergistic eﬀects between microbial
pathogeniccompoundshavebeenobserved.WhereasLTA
can cause only moderate hypotension, PepG coadminis-
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tered with LTA induces multiorgan dysfunction and death
inrats[8,9].BactDNAalsoincreasesthetoxicityofLPSin
mice [10]. However, synergistic eﬀects between bactDNA
and PepG have not been reported. Moreover, although
IL-1, induced by bacterial toxins including bactDNA, has
been shown to induce TF in endothelial cells [11, 12], the
eﬀect of bactDNA on the regulation of TF in monocytes
has not been described.
The goal of this study was to investigate the eﬀect
of bactDNA and PepG, on the induction of a marker
of inﬂammation, TNF-α, in human peripheral blood
mononuclear cells (PBMC), and of a coagulation marker,
TF,inmonocytes,andtotestthehypothesisthatbactDNA
and PepG can exert synergistic eﬀects.
MATERIALS AND METHODS
Peripheral blood mononuclear cells were prepared by
Ficoll separation of peripheral blood from healthy vol-
u n t e e r sa sp r e v i o u s l yd e s c r i b e d[ 13]. Mononuclear cells
were plated at a density of 106 cells/mL in 1.5mLRPMI
1640 (Irvine Scientiﬁc, Santa Ana, Calif), supplemented
with 100U/mL penicillin/streptomicin, 2mM glutamine,
and 3% fetal calf serum, and treated with PepG (Sigma,
St Louis, Mich), bactDNA (KM Biomedicals, Aurora,
Ohio; LPS < 0.2EU/mL measured by the limulus ame-
bocyte lysate assay [13]), or both. TNF-α was measured
by ELISA from the culture supernatant after 5-hour incu-
bation and elimination of nonadherent cells. The TNF-α













































































































































Figure 1. TNF-α secreted by PBMC (a) and monocytic TF (b) after treatment with PepG (white bar), bactDNA (black bar), or
both simultaneously at the same concentration as when added alone (hatched bar). The numbers following P and D indicate the
concentrations of PepG and bactDNA in µg/mL, respectively. P<. 05 for TNF-α and TF, when comparisons were made between the
sum of the eﬀects of PepG (1 or 0.3µg/mL) and bactDNA alone at all concentrations tested, and when PepG and bactDNA were added
together; Student t test (n = 4).
The coeﬃcient of variation for the TNF-α ELISA was less
than 8.9% for duplicate measurements of a single culture.
The lowest detection limit was 10pg/mL.
Tissue factor in monocytes was evaluated from the
corresponding PBMC cultures used for TNF-α analysis.
After 5 hours of treatment, TF was extracted from the
adherent cells with phosphate buﬀered saline containing
0.1% Triton X100 as recommended by the manufacturer
for subsequent TF ELISA. The Imubind kit from Ameri-
can Diagnostica (Greenwich, Conn) was used. The coeﬃ-
cient of variation for the TF ELISA was less than 9.7% for
duplicate measurements of a single culture. The sensitiv-
ity of the assay was 10pg/mL.
Numerical data were analyzed by using the Student t
test. A P value less than .05 was considered statistically
signiﬁcant.
RESULTS
Induction of TNF-α secretion in PBMC cultures was
used as an in vitro assay for the determination of an in-
ﬂammatory reaction. TF is an initiator of coagulation and
wasusedasanindicatorofaprocoagulantreaction.There
was no detectable TNF-α or TF in untreated cells, and no
signiﬁcant diﬀerence in the amount of proteins extracted
from monocytes between treatment conditions was mea-
sured (not shown). Both PepG and bactDNA applied in-
dividually to PBMC were able to induce TNF-α and TF
in a dose-response fashion (Figure 1). In presence of high
concentration of PepG (3µg/mL), adding bactDNA did
not generate signiﬁcantly more TNF-α or TF, except at
15µg/mLbactDNAforTNF-α.However,whenlowercon-
centrations of PepG (1µg/mL or 0.3µg/mL) were used,120 Marie-Claude Amoureux et al 2005:2 (2005)
treatment with bactDNA and PepG simultaneously gen-
erated more TNF-α and TF than when adding the eﬀect
of the two compounds used separately (P<. 05) (Fig-
ure 1). The induction of TNF-α and TF was up to 15-
and10-foldhigher,respectively,whenPepGandbactDNA
were present in conjunction, than when adding the eﬀect
of the two molecules alone. These results indicate that
PepG and bactDNA act in synergy, even when bactDNA
a l o n ed o e sn o ti n d u c ed e t e c t a b l eT N F - α or TF by it-
self.
DISCUSSION
The present results demonstrate the concomitant
induction of TNF-α a n dT Fb yP e p Ga n db a c t D N A
in PBMC, and a synergistic eﬀect between the two
molecules. Although the molecular mechanism for this
synergy remains to be elucidated, it could involve direct
eﬀects on common downstream signaling pathways, or
indirect eﬀects mediated by secreted compounds follow-
ing PepG or bactDNA action.
The increase in TF expression on monocytes by
bactDNA is a new ﬁnding and may have signiﬁcance in
disseminated intravascular coagulation. Indeed, an in-
crease in TF elicited by PepG and/or bactDNA could have
l o c a la sw e l la ss y s t e m i ce ﬀects, as TF has been shown to
bepresentoncirculatingmonocytes[14].TNF-αisanim-
portant early mediator of host responses to pyrogens and
is the only endogenous mediator capable of triggering the
entire spectrum of metabolic, hemodynamic, tissue, and
cytokine cascade responses of septic shock. These results
are also signiﬁcant in as much as the crosstalk between in-
ﬂammationandcoagulationisanaspecttoconsiderinthe
quest of an eﬀective therapy for septic shock. The syner-
gistic eﬀects of bactDNA and PepG also have implications
for the pathogenesis of sepsis, where each molecule, al-
though present at low concentrations in vivo, is likely to
amplify the eﬀect of another one, as hypothesized previ-
ously [15].
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